Technical Analysis for JANX - Janux Therapeutics, Inc.

Grade Last Price % Change Price Change
C 38.81 -1.62% -0.64
JANX closed down 1.62 percent on Monday, March 18, 2024, on 26 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Inside Day Range Contraction -1.62%
Wide Bands Range Expansion -1.62%
Wide Bands Range Expansion 2.75%
MACD Bearish Signal Line Cross Bearish -2.78%
NR7 Range Contraction -2.78%
Narrow Range Bar Range Contraction -2.78%
Multiple of Ten Bearish Other -2.78%
Wide Bands Range Expansion -2.78%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 14 hours ago
Up 2% about 14 hours ago
60 Minute Opening Range Breakout about 14 hours ago
Down 5% about 15 hours ago
Down 3% about 16 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. It is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. The company was incorporated in 2017 and is headquartered in La Jolla, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Immunology Immune System Tumor Platform Technology Chimeric Antigen Receptor T Cell T Cell Clusters Of Differentiation

Is JANX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 58.6936
52 Week Low 5.65
Average Volume 790,602
200-Day Moving Average 12.78
50-Day Moving Average 19.73
20-Day Moving Average 35.20
10-Day Moving Average 40.05
Average True Range 4.27
RSI (14) 64.41
ADX 47.65
+DI 31.77
-DI 14.83
Chandelier Exit (Long, 3 ATRs) 45.87
Chandelier Exit (Short, 3 ATRs) 21.10
Upper Bollinger Bands 60.95
Lower Bollinger Band 9.45
Percent B (%b) 0.57
BandWidth 146.33
MACD Line 6.36
MACD Signal Line 7.30
MACD Histogram -0.9429
Fundamentals Value
Market Cap 1.79 Billion
Num Shares 46.2 Million
EPS -1.47
Price-to-Earnings (P/E) Ratio -26.40
Price-to-Sales 51.42
Price-to-Book 1.22
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.07
Resistance 3 (R3) 43.09 41.70 42.36
Resistance 2 (R2) 41.70 40.61 41.69 42.12
Resistance 1 (R1) 40.25 39.94 39.56 40.23 41.89
Pivot Point 38.86 38.86 38.51 38.85 38.86
Support 1 (S1) 37.41 37.77 36.72 37.39 35.73
Support 2 (S2) 36.02 37.10 36.01 35.50
Support 3 (S3) 34.57 36.02 35.26
Support 4 (S4) 34.55